Literature DB >> 3139950

Polyunsaturated fatty acids of serum lipids in myocardial infarction.

J W Crofts1, P L Ogburn, S B Johnson, R T Holman.   

Abstract

Two groups of volunteers had blood drawn for serum analysis of fatty acids. The first group was comprised of patients admitted to the hospital with possible myocardial infarction (MI). Blood was drawn at admission and at 12, 24 and 48 hr. These patients were subsequently divided into three groups, those with MI, those without (No MI) and those taking prostaglandin inhibitors (PGI), on the basis of the cardiac enzymes, electrocardiograms and clinical history. A fourth group of Normal nonstressed people was also drawn at 0, 12, 24 and 48 hr for comparison. Fatty acid composition of phospholipids (PL), nonesterified fatty acids (NEFA), triglycerides (TG) and cholesteryl esters (CE) was determined by capillary gas chromatography (GC), and comparisons were made between the MI, No MI, PGI and Normal groups. Total NEFA were significantly elevated in patients admitted for possible MI compared with Normals. Those patients with MI had marginally higher levels of NEFA than the No MI group at each sampling time, but this difference was not statistically significant. The MI, No MI and PGI groups had significantly different fatty acid patterns in NEFA with reduced percentages of arachidonic acid (AA) than controls. The fatty acid patterns in the four lipid classes showed few significant differences comparing the MI, No MI and PGI groups. The regular use of prostaglandin inhibitors before hospitalization for chest pain was associated with a reduced frequency of MI (p less than 0.002). NEFA levels, nonesterified AA levels and fatty acid patterns in this group did not differ from those patients not taking prostaglandin inhibitors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139950     DOI: 10.1007/bf02535594

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction.

Authors:  M F Oliver; V A Kurien; T W Greenwood
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

2.  Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction.

Authors:  S P Allison; M J Chamberlain; P Hinton
Journal:  Br Med J       Date:  1969-12-27

3.  Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.

Authors:  K Breddin; D Loew; K Lechner; K Uberla; E Walter
Journal:  Thromb Haemost       Date:  1979-02-28       Impact factor: 5.249

4.  Aspirin and secondary mortality after myocardial infarction.

Authors:  P C Elwood; P M Sweetnam
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

5.  Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.

Authors: 
Journal:  N Engl J Med       Date:  1978-02-09       Impact factor: 91.245

6.  Sulfinpyrazone in the prevention of sudden death after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

7.  Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man.

Authors:  H S Mueller; S M Ayres
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

8.  Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction.

Authors:  M J Tansey; L H Opie
Journal:  Lancet       Date:  1983-08-20       Impact factor: 79.321

9.  Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction.

Authors:  H G McDaniel; S E Papapietro; W J Rogers; J A Mantle; L R Smith; R O Russell; C E Rackley
Journal:  Am Heart J       Date:  1981-07       Impact factor: 4.749

10.  Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.

Authors: 
Journal:  Circulation       Date:  1980-09       Impact factor: 29.690

View more
  2 in total

1.  Changes in fatty acid composition of rat serum induced by a free radical generator.

Authors:  V Ruiz-Gutierrez; F J Muriana
Journal:  Bull Environ Contam Toxicol       Date:  1992-07       Impact factor: 2.151

2.  Hyperphagia modifies FA profiles of plasma phospholipids, plasma FFA, and adipose tissue TAG.

Authors:  Gudrun V Skuladottir; Pall I Olason; Logi Jonsson; Jon O Skarphedinsson; Vedis H Eriksdottir; Palmi Th Atlason; Leifur Franzson; Helgi B Schiöth
Journal:  Lipids       Date:  2003-11       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.